Rift Valley Fever (RVF) Treatment Market Outlook:
Rift Valley Fever (RVF) Treatment Market size was over USD 2.06 billion in 2025 and is poised to exceed USD 3.45 billion by 2035, growing at over 5.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of rift valley fever treatment is evaluated at USD 2.16 billion.
The growth of the market can be attributed to the rising cases of rift valley fever. Mosquito-borne rift valley fever seems to grow in humans and animals owing to factors such as climate change that are creating ideal mosquito breeding grounds. Further, increased outbreaks accelerate the demand for supportive care and highlight the urgent need for specific treatments. In people, the total RVF CFR was determined to be 27.5%. In people and animals, the overall pooled prevalence was 7.8% and 9.3%, respectively.
As the threat of river valley fever expands, governments and research institutions are investing more money in developing new treatments and vaccines for the disease. This investment is likely to lead to the development of new and more effective treatments for river valley fever in the forecast period. Therefore, the development of new treatment options and medications for the river valley fever cure is further predicted to drive the growth of this market in the future times.
